ML345 is a potent and selective NLRP3 inflammasome inhibitor with anti-inflammatory activity

Hualong Lin(Wenzhou Medical University), Xiaohong Wang(South China University of Technology)

Molecular Biomedicine

November 13, 2025

10.1186/s43556-025-00363-7

Cited by 2

Related Papers

Protection against persistence of hepatitis C

|The Lancet|2002|439

Cellular immune selection with hepatitis C virus persistence in humans

|The Journal of Experimental Medicine|2005|304

A phage-based magnetic relaxation switching biosensor using bioorthogonal reaction signal amplification for Salmonella detection in foods

|Food Chemistry|2022|76

Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observational study

|Thoracic Cancer|2019|26